Small peptide tat-akpd for treating ischemic brain injury and its application
A technology of TAT-AKPD and ischemic brain injury, which is applied in the field of biomedicine, can solve the problems of ineffective treatment of neuron damage, and achieve the effects of convenient drug administration, reducing cell apoptosis, and ensuring effectiveness
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Embodiment of the present invention is small peptides TAT-AKPD treatment of ischemic brain injury embodiment used, based Procaspase-7 binding and transfer between XIAP and nitrosylated designed, having the sequence: H-YGRKKRRQRRR-AKPD-OH , SEQ ID NO.1.
[0021]Endogenous Procaspase-7 occurred after cerebral ischemia, and hydrolyzed activation occurs, which in turn leads to apoptosis. The activity of caspases is regulated by apoptosis inhibitory protein family (IAPS), wherein X-link inhibitos Protein, XIAP is directly combined with Procaspase-7 through its BIR domain. And inhibit its activity. After the cerebral ischemia, XIAP has a nitrogenization, thereby inhibiting its anti-apoptotic activity.
[0022] According to the amino acid sequence of Procaspase-7 and XIAP binding sites, the four amino acids of the small peptide TAT-AKPD, and the procaspase-7 AKPD constitute a motif, responsible for binding to XIAP; TAT derived from a group of 11 amino acids on a slow virus The seq...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com